Linscott Walt Addison 4
4 · Indaptus Therapeutics, Inc. · Filed Jan 28, 2022
Insider Transaction Report
Form 4
Linscott Walt Addison
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-26+45,850→ 45,850 totalExercise: $4.90Exp: 2032-01-26→ Common Stock (45,850 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.